Zhejiang Xianju Pharmaceutical Co.,Ltd.

SZSE:002332 Stock Report

Market Cap: CN¥10.2b

Zhejiang Xianju PharmaceuticalLtd Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Weihua Jin

Chief executive officer

CN¥1.2m

Total compensation

CEO salary percentagen/a
CEO tenure2yrs
CEO ownershipn/a
Management average tenure8yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

There's No Escaping Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Muted Earnings

Dec 10
There's No Escaping Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Muted Earnings

Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Seems To Use Debt Quite Sensibly

Oct 16
Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Seems To Use Debt Quite Sensibly

A Look At The Intrinsic Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)

Sep 03
A Look At The Intrinsic Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)

Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Will Pay A Dividend Of CN¥0.30

Jun 02
Zhejiang Xianju PharmaceuticalLtd (SZSE:002332) Will Pay A Dividend Of CN¥0.30

Estimating The Fair Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)

Apr 15
Estimating The Fair Value Of Zhejiang Xianju Pharmaceutical Co.,Ltd. (SZSE:002332)

There Is A Reason Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Price Is Undemanding

Mar 05
There Is A Reason Zhejiang Xianju Pharmaceutical Co.,Ltd.'s (SZSE:002332) Price Is Undemanding

CEO

Weihua Jin (49 yo)

2yrs

Tenure

CN¥1,226,700

Compensation

Mr. Weihua Jin serves as Non-Independent Director at Zhejiang Xianju Pharmaceutical Co.,Ltd. since December 23, 2022. He was Deputy General Manager of Zhejiang Xianju Pharmaceutical Co.,Ltd.from November...

Leadership Team

NamePositionTenureCompensationOwnership
Weihua Jin
GM & Directorno dataCN¥1.23mno data
Yao Hua Wang
CFO, Financial Director & Chief Accountant11.6yrsCN¥940.20kno data
Wangwei Zhang
Deputy GM8yrsCN¥758.00kno data
Carlo Cartasegna
Deputy General Manager7yrsCN¥918.10kno data

8.0yrs

Average Tenure

51yo

Average Age

Experienced Management: 002332's management team is seasoned and experienced (8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Weihua Jin
GM & Director2yrsCN¥1.23mno data
Wangwei Zhang
Deputy GM8yrsCN¥758.00kno data
Chi Zhang
Member of Supervisory Board11yrsno datano data
Yusong Zhang
Chairmanno dataCN¥1.45mno data
Weiwu Chen
Non-Independent Director2yrsno datano data
Guo Jun Zhang
Director17yrsno datano data
Hongying Zhang
Independent Director5yrsCN¥72.00kno data
Yanqin Li
Supervisor5yrsno datano data
Baohu Cao
Non-Independent Director2yrsno datano data
Yunhong Hao
Independent director3.6yrsCN¥72.00kno data
Bin Liu
Independent Director2yrsCN¥72.00kno data
Tianfei Wu
Chairman of the Supervisory Board2yrsno datano data

3.6yrs

Average Tenure

55yo

Average Age

Experienced Board: 002332's board of directors are considered experienced (3.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 05:19
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Zhejiang Xianju Pharmaceutical Co.,Ltd. is covered by 15 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Yue GaoChangjiang Securities Co. LTD.
Pei ChengChina Galaxy Securities Co., Ltd.
Feifei XuChina Merchants Securities Co. Ltd.